GAB
GDV
GCV
BCV
GGN

Agnes Mullady

Known title: DirectorCIK: 0001387823

Agnes Mullady's purchase track record

How the stock did after each of Agnes Mullady's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
9
of 9 since February 17, 2022
Stock higher 6 months later
0%
3 months: 11%
Median 6-month return
-5.2%
3 months: -2.6%
Beat the S&P 500
11%
median -1.4% vs. index
PurchaseStockAmount3 months6 months
10/11/2024GDV$100K-1.6%-5.5%
2/17/2022GRX$2K-10.5%-3.4%
2/17/2022BCV$3K-16.5%-6.5%
2/17/2022GNT$805-2.6%-8.3%
2/17/2022GGZ$2K-14.1%-11.7%
2/17/2022GGN$575+3.9%-3.5%
2/17/2022GDV$4K-11.9%-3.3%
2/17/2022GCV$912-1.7%-5.2%
2/17/2022GAB$1K-1.8%-2.6%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 7, 2026

SeekingAlpha Highlights GAB in Income Fund Analysis. A recent SeekingAlpha analysis named GAB among funds potentially suitable for investors seeking around $5,000 in annual dividend income. The Gabelli Equity Trust's 10.31% dividend yield is notably high compared to broader market averages, which explains its relevance in income-focused fund comparisons. The stock currently trades near the middle of its 52-week range between $5.28 and $6.31, with momentum indicators showing neutral readings.

this person other insiders at GAB

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 12, 2026

GDV Preferred Stock Analysis Published. A new article on Seeking Alpha provides a comparative analysis of GDV's preferred shares, specifically classes H and K. This type of detailed review helps investors understand the specific terms and relative value of these income-focused instruments. The common shares currently trade with a low trailing P/E ratio of 5.1, sitting within a 52-week range of $26.14 to $31.00.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

Gabelli Convertible Fund Releases Q2 2026 Commentary. Gabelli Convertible and Income Securities Fund has published its second-quarter 2026 commentary. This update provides investors with the fund's latest portfolio insights and performance context. The stock is currently trading near its 52-week low, which may influence how readers interpret the new fund disclosures.

this person other insiders at BCV
this person other insiders at GGN

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

GAMCO Natural Resources releases Q2 2026 commentary. GAMCO Natural Resources released its Q2 2026 commentary. The update gives investors an overview of the trust’s performance and outlook for the next quarter. The trust has a low trailing P/E of 3.0 and a dividend yield of 8.34%. The stock is trading near its 52‑week range and close to a support level of $8.10.

this person other insiders at GNT

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

GGZ: Global Small-Cap Equity Outlook Discussed. A recent article explores the potential for global small-cap equities, providing context for the Gabelli Global Small and Mid Cap Value Trust. The fund currently trades near the lower end of its 52-week range, with a low trailing P/E ratio. Technical indicators show the stock testing key support levels.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

Gabelli Healthcare & Wellness Trust Releases Q2 2026 Commentary. The Gabelli Healthcare & Wellness Trust has published its Q2 2026 commentary, providing an update on the trust's recent performance and outlook. This disclosure serves as a standard periodic update for stakeholders. The trust currently trades within a 52-week range of $8.80 to $10.20, with recent activity near the lower end of that band.

Transaction History

GAB▼ Sell$75
GAB▼ Sell$930
GDV▲ Buy$100K
GCV▲ Buy$912
BCV▲ Buy$3K
GGN▲ Buy$575
GNT▲ Buy$805
GAB▲ Buy$1K
GGZ▲ Buy$2K
GDV▲ Buy$4K
GRX▲ Buy$2K

We use analytics to understand how market-wall is used. No personal data is sold.